AtriCure reports solid 4Q revenue growth

Cardiac medical device maker AtriCure today announced preliminary financial results for fourth quarter and full year 2012.

Preliminary revenue for the fourth quarter of 2012 is expected to be approximately $18.4 million, about 9.5% more than fourth quarter 2011. Preliminary revenue for full year 2012 is expected to be $70.2 million, reflecting year-over-year growth of 9.1%.

West Chester-based AtriCure manufactures and markets cardiac surgical ablation systems designed to treat atrial fibrillation (AF) and systems for the exclusion of the left atrial appendage. The company brought on Mike Carrel as president and CEO AtriCure in November.

“In my first two months at AtriCure, I have spent considerable time evaluating the strategic and operational aspects of the company through in depth conversations with employees, clinical partners, customers, and shareholders,” Carrel said. “I have found many strengths—we have truly differentiated technology, solid customer relationships, an unparalleled training program, and a talented and committed group of employees.

Read AtriCure’s full news release here.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

NanoLogix developing rapid test for Ebola virus (video) | WYTV33 Youngstown, October 21, 2014

Analytic, a partnership of Anatrace and Microlytic: enabling membrane protein research | PR Web, October 21, 2014

Quasar Energy Group uses organic waste to produce renewable energy | Todays Energy Solutions, October 21, 2014

Frank Samuel, President of VentureOhio and former BioOhio President dies in auto accident | Geauga County Maple Leaf, October 21, 2014

Milo Biotechnology’s follistatin gene therapy increases function in Becker Muscular Dystrophy patients | PR Newswire, October 20, 2014

OSU Wexner Medical Center study: new implantable device to control heart failure shows promising results | Todays Medical Developments, October 17, 2014

Assurex Health gets $6M funding for clinical trial related to patients with depression or schizophrenia | Cincinnati Business Courier, October 17, 2014

University of Cincinnati lands grant to attack hepatitis C among needle users in 20 counties | WCPO9 Cincinnati, October 16, 2014

Control Bionics interview, developing technology that enables individuals with debilitating conditions to communicate | The Clermont Sun, October 16, 2014

BioOhio member Oralectrics spinout Zumby opens crowdfunding campaign | Cleveland.com, October 16, 2014

Ohio State sophomore Peeyush Shrivastava of Genetesis named a finalist in $5M 43North business plan competition | Columbus Business First, October 16, 2014

Navidea hires Rick Gonzalez as CEO from Spectrum Pharmaceuticals, replaces Michael Goldberg, Navidea’s lead investor | Columbus Business First, October 15, 2014

Health Care DataWorks’ Chief Data Scientist to present at healthcare conference sponsored by HIMSS Georgia Chapter | PR Web, October 15, 2014

FDA approves expanded use of Navidea’s Lymphoseek for lymphatic mapping in solid tumors | Business Wire, October 15, 2014

Crowdfunding launches today for Animal Oralectrics’ new medical device for dogs that fights oral bacteria while playing | PR Newswire, October 15, 2014

NanoLogix technology being configured for rapid Ebola and Enterovirus detection | Business Wire, October 14, 2014

Nanotronics Imaging releases nSPEC 3D, powerful microscope that captures 3D images at nanoscale, in lightning speed | Business Wire, October 14, 2014

Cincinnati Children’s Hospital Medical Center announces a new treatment designed to save more eyes from cancer | PR Newswire, October 14, 2014

Ischemia Care raises $1.9M for stroke detection technology | MedCity News, October 13, 2014

STERIS to acquire Synergy Health for $1.9 Billion in cash and stock | STERIS, October 13, 2014